Search bioRxivSearch

Biology subjects

Johnson, S. R.

Publications and source records attributed to Johnson, S. R..

2 recordsLinked to original sources

Generating novel protein sequences using Gibbs sampling of masked language models

Recently developed language models (LMs) based on deep neural networks have demonstrated the ability to generate fluent natural language text. LMs pre-trained on protein sequences have shown state of the art performance on a variety of downstream tasks. Protein LMs have also been used to generate novel protein sequences. In the present work we use Gibbs sampling of BERT-style LMs, pre-trained on protein sequences using the masked language modeling task, to generate novel protein sequences. We evaluate the quality of the generated sequences by comparing them to natural sequences from the same family. In particular, we focus on proteins from the chorismate mutase type II family, which has been used in previous work as an example target for protein generative models. We find that the Gibbs sampling process on BERT-style models pretrained on millions to billions of protein sequences is able to generate novel sequences that retain key features of related natural sequences. Further, we find that smaller models fine-tuned or trained from scratch on family-specific data are able to equal or surpass the generation quality of large pre-trained models by some metrics. The ability to generate novel natural-like protein sequences could contribute to the development of improved protein therapeutics and protein-catalysts for industrial chemical production.

synthetic biology

Lysyl oxidase-like 2 (LOXL2) is Increased in Asthma and Contributes to Asthmatic Airway Remodelling

Airway smooth muscle cells (ASM) are fundamental to asthma pathogenesis, influencing bronchoconstriction, airway hyper-responsiveness, and airway remodelling. Extracellular matrix (ECM) can influence tissue remodelling pathways, however, to date no study has investigated the effect of ASM ECM stiffness and crosslinking on the development of asthmatic airway remodelling. We hypothesised that TGF{beta} activation by ASM is influenced by ECM in asthma and sought to investigate the mechanisms involved. This study combines in vitro and in vivo approaches: human ASM cells were used in vitro to investigate basal TGF{beta} activation and expression of ECM crosslinking enzymes. Human bronchial biopsies from asthmatic and non-asthmatic donors were used to confirm LOXL2 expression ASM. A chronic ovalbumin model of asthma was used to study the effect of LOXL2 inhibition on airway remodelling. We found that ASM cells from asthmatics activated more TGF{beta} basally than non-asthmatic controls and that diseased cell-derived ECM influences levels of TGF{beta} activated. Our data demonstrate that the ECM crosslinking enzyme LOXL2 is increased in asthmatic ASM cells and in bronchial biopsies. Crucially, we show that LOXL2 inhibition reduces ECM stiffness and TGF{beta} activation in vitro, and can reduce subepithelial collagen deposition and ASM thickness, two features of airway remodelling, in an ovalbumin mouse model of asthma. These data are the first to highlight a role for LOXL2 in the development of asthmatic airway remodelling and suggest that LOXL2 inhibition warrants further investigation as a potential therapy to reduce remodelling of the airways in severe asthma.

cell biology